Drug Manufacturers - Specialty & Generic
Compare Stocks
2 / 10Stock Comparison
SISI vs CHNR
Revenue, margins, valuation, and 5-year total return — side by side.
Waste Management
SISI vs CHNR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Waste Management |
| Market Cap | $1K | $42M |
| Revenue (TTM) | $10M | $0.00 |
| Net Income (TTM) | $-39M | $-14M |
| Gross Margin | 6.9% | — |
| Operating Margin | -143.5% | — |
| Total Debt | $30M | $0.00 |
| Cash & Equiv. | $366K | $3M |
SISI vs CHNR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | Mar 26 | Return |
|---|---|---|---|
| Shineco, Inc. (SISI) | 100 | 0.0 | -100.0% |
| China Natural Resou… (CHNR) | 100 | 10.0 | -90.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SISI vs CHNR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SISI is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 16.8%, EPS growth 41.1%, 3Y rev CAGR 48.0%
- Lower volatility, beta -0.51, Low D/E 81.1%, current ratio 0.76x
- Beta -0.51, current ratio 0.76x
CHNR carries the broadest edge in this set and is the clearest fit for long-term compounding.
- -93.5% 10Y total return vs SISI's -100.0%
- 0.0% margin vs SISI's -398.5%
- -2.3% vs SISI's -99.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.8% revenue growth vs CHNR's -100.0% | |
| Quality / Margins | 0.0% margin vs SISI's -398.5% | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -2.3% vs SISI's -99.2% | |
| Efficiency (ROA) | -5.3% ROA vs SISI's -45.5%, ROIC -0.0% vs -21.6% |
SISI vs CHNR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
SISI vs CHNR — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
SISI leads this category, winning 1 of 1 comparable metric.
Income & Cash Flow (Last 12 Months)
SISI and CHNR operate at a comparable scale, with $10M and $0 in trailing revenue.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $10M | $0 |
| EBITDAEarnings before interest/tax | -$9M | -$12M |
| Net IncomeAfter-tax profit | -$39M | -$14M |
| Free Cash FlowCash after capex | $2M | -$6M |
| Gross MarginGross profit ÷ Revenue | +6.9% | — |
| Operating MarginEBIT ÷ Revenue | -143.5% | — |
| Net MarginNet income ÷ Revenue | -4.0% | — |
| FCF MarginFCF ÷ Revenue | +19.4% | — |
| Rev. Growth (YoY)Latest quarter vs prior year | -97.0% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +92.0% | +91.3% |
Valuation Metrics
Evenly matched — SISI and CHNR each lead in 1 of 2 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $1,352 | $42M |
| Enterprise ValueMkt cap + debt − cash | $29M | $41M |
| Trailing P/EPrice ÷ TTM EPS | -0.00x | -88.68x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | — |
| Price / SalesMarket cap ÷ Revenue | 0.00x | — |
| Price / BookPrice ÷ Book value/share | 0.00x | 3.21x |
| Price / FCFMarket cap ÷ FCF | — | — |
Profitability & Efficiency
CHNR leads this category, winning 6 of 7 comparable metrics.
Profitability & Efficiency
CHNR delivers a -15.7% return on equity — every $100 of shareholder capital generates $-16 in annual profit, vs $-149 for SISI.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -149.3% | -15.7% |
| ROA (TTM)Return on assets | -45.5% | -5.3% |
| ROICReturn on invested capital | -21.6% | -0.0% |
| ROCEReturn on capital employed | -31.6% | -0.0% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 2 |
| Debt / EquityFinancial leverage | 0.81x | — |
| Net DebtTotal debt minus cash | $29M | -$3M |
| Cash & Equiv.Liquid assets | $366,140 | $3M |
| Total DebtShort + long-term debt | $30M | $0 |
| Interest CoverageEBIT ÷ Interest expense | -18.13x | -263.29x |
Total Returns (Dividends Reinvested)
CHNR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CHNR five years ago would be worth $721 today (with dividends reinvested), compared to $0 for SISI. Over the past 12 months, CHNR leads with a -2.3% total return vs SISI's -99.2%. The 3-year compound annual growth rate (CAGR) favors CHNR at -41.2% vs SISI's -96.4% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +1.7% | +22.2% |
| 1-Year ReturnPast 12 months | -99.2% | -2.3% |
| 3-Year ReturnCumulative with dividends | -100.0% | -79.7% |
| 5-Year ReturnCumulative with dividends | -100.0% | -92.8% |
| 10-Year ReturnCumulative with dividends | -100.0% | -93.5% |
| CAGR (3Y)Annualised 3-year return | -96.4% | -41.2% |
Risk & Volatility
Evenly matched — SISI and CHNR each lead in 1 of 2 comparable metrics.
Risk & Volatility
SISI is the less volatile stock with a -0.51 beta — it tends to amplify market swings less than CHNR's 1.12 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHNR currently trades 52.4% from its 52-week high vs SISI's 0.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.51x | 1.12x |
| 52-Week HighHighest price in past year | $45.50 | $8.20 |
| 52-Week LowLowest price in past year | $0.00 | $3.16 |
| % of 52W HighCurrent price vs 52-week peak | +0.7% | +52.4% |
| RSI (14)Momentum oscillator 0–100 | 59.3 | 55.2 |
| Avg Volume (50D)Average daily shares traded | 133 | 893K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — |
| Price TargetConsensus 12-month target | — | — |
| # AnalystsCovering analysts | — | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 0 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
CHNR leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). SISI leads in 1 (Income & Cash Flow). 2 tied.
SISI vs CHNR: Frequently Asked Questions
7 questions · data-driven answers · updated daily
01Which is the better long-term investment — SISI or CHNR?
Over the past 5 years, China Natural Resources, Inc.
(CHNR) delivered a total return of -92. 8%, compared to -100. 0% for Shineco, Inc. (SISI). Over 10 years, the gap is even starker: CHNR returned -93. 5% versus SISI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
02Which is safer — SISI or CHNR?
By beta (market sensitivity over 5 years), Shineco, Inc.
(SISI) is the lower-risk stock at -0. 51β versus China Natural Resources, Inc. 's 1. 12β — meaning CHNR is approximately -321% more volatile than SISI relative to the S&P 500.
03Which is growing faster — SISI or CHNR?
On earnings-per-share growth, the picture is similar: China Natural Resources, Inc.
grew EPS 95. 9% year-over-year, compared to 41. 1% for Shineco, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
04Which has better profit margins — SISI or CHNR?
China Natural Resources, Inc.
(CHNR) is the more profitable company, earning 0. 0% net margin versus -229. 0% for Shineco, Inc. — meaning it keeps 0. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CHNR leads at 0. 0% versus -174. 1% for SISI. At the gross margin level — before operating expenses — SISI leads at 9. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Which pays a better dividend — SISI or CHNR?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
06Is SISI or CHNR better for a retirement portfolio?
For long-horizon retirement investors, Shineco, Inc.
(SISI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 51)). Both have compounded well over 10 years (SISI: -100. 0%, CHNR: -93. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
07What are the main differences between SISI and CHNR?
These companies operate in different sectors (SISI (Healthcare) and CHNR (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: SISI is a small-cap high-growth stock; CHNR is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.